Most Popular Stories
Poll
Featured Jobs
-
Dir/Quality Initiatives Job for Texas
StaffPointe, LLC - Fort Worth, TX -
RN/Director of Compliance Job in Oklahoma
StaffPointe, LLC - Tulsa, OK -
Dir of Nursing/LTC Job for Kentucky
StaffPointe, LLC - Lexington, KY -
HOD Cardiology Nurse Job for Libya
StaffPointe, LLC - confidential, DC -
Pediatrician
Executive Office Services - Philadelphia, PA
Events
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
Hot Topics >> Reader's Corners | Health plan CEO paychecks | Twitter | iPhone healthcare apps
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Food and Drug Administration (FDA)
- Electronic Medical Records (EMRs)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- prescription drugs
- UnitedHealth Group
- pharmaceutical companies
Canada moves to block drug exports
This time it appears the Canadians are serious. Health Minister Ujjal Dosanjh said on Wednesday that Canadian lawmakers will draft legislation banning the bulk export of prescription drugs to the US. Legislators will also consider a measure which would make it difficult for Canadian doctors to write prescriptions for patients without seeing them. About 2 million Americans rely on inexpensive prescription drugs from Canada, according to some estimates. Sales are believed to be worth only about $800 million per year (compared to overall US sales of more than $220 billion).
In theory, the end of the Canadian supply should prove a major backdoor win for the pharmaceutical industry. Many critics, however, argue that in the era of globalization, reimportation may be a difficult economic problem to contain. The New York Times notes that the move may give "other foreign online suppliers a new competitive edge and encourage Canadian companies to warehouse more of their inventories in other countries."
- see this story from The New York Times
Related Stories
- Nursing homes forced to address chronic pain management
- Study: Recession could pump up market for OTC drugs
- VT may toughen pharma regulations; Study says tight privacy laws slow EMR adoption;
- SPOTLIGHT: Should FDA's info be in all DTC ads?
- Trend: States try to counter pharma drug marketing
- WA attempts prescription data mining ban
- Calif. healthcare proposals rejected in special election
- Governors Assoc. releases Medicaid recommendations
- CT may require health plans to offer autism coverage
- Medicare may test 'value-based' coverage design
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |






Click here to get the FierceHealthcare email newsletter for FREE!